Why the study?
Osteosarcoma has high disability and mortality rates and poor prognosis, and the role of ANGPTL2 in this disease required investigation.
Key points are not available for this paper at this time.
Population
Microarray datasets GSE16088 and GSE36001 alongside osteosarcoma tissues
Comparison
ANGPTL2 high expression vs low expression
Design
Bioinformatic analysis and laboratory tissue validation study
Answers are grounded in this paper and cite their sources.
ANGPTL2 upregulation may inform osteosarcoma risk stratification; leaves open prospective validation before clinical adoption.
Osteosarcoma mostly occurs in adolescents, with high disability and mortality rates and poor prognosis. Angiopoietin-like protein 2 (ANGPTL2) is a secreted glycoprotein protein, which plays important roles in cellular processes and various diseases. Microarray gene expression data GSE16088 and GSE36001 were downloaded from Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo). The Complex Heatmap package was used to construct heatmaps, the gglot2 R language package to plot volcanoes and differential expression data, and the “VennDiagram” R language package to plot Wayne plots. Western booting and qRT-PCR was used to detect ANGPTL2 expression in osteosarcoma tissues. proteins. In addition, the GeneMANIA database (http://www.genemania.org) was cited to predict the ANGPTL2 interaction network. We used the single-sample gene-set enrichment analysis (ss GSEA) algorithm to quantify the immune infiltration of osteosarcoma. In the GSE16088 database there were 5005 that met the selected threshold of |log2(FC)| > 1 and P <0.05, of which 2719 were highly expressed and 2286 were lowly expressed. WB and qRT-PCR results showed that ANGPTL2 was significantly up-regulated in osteosarcoma tissues. ssGSEA showed that high ANGPTL2 expression in osteosarcoma patients had a worse prognosis. ssGSEA showed that high ANGPTL2 expression was correlated with Mast cells and Th1 cells. Collectively, ANGPTL2 can be an independent prognostic biomarker and correlated with immune infiltration in osteosarcoma.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: